InsidersTradesSigma
Discover the complete record of transactions filed by Fickenscher James E, Chief Financial Officer. Insider active across 1 company, notably Zynerba Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been logged. Activity tracked since 26 January 2022. The latest transaction was disclosed on 26 January 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
James E. Fickenscher is the Chief Financial Officer at Zynerba Pharmaceuticals, Inc. In this role, he oversees the financial management of the company, ensuring compliance and efficiency in financial operations.